ACTN1 Promotes Cell Invasion, Migration, and EMT in Thyroid Cancer and is Associated with Immune Infiltration

Overview

Journal Sci Rep

Specialty Science

Date 2024 Dec 31

PMID 39738470

Authors

Song Chen

Xue Luo

Wentai Wang

Xing-Hong Chen

Ning Ma

Xue-Yin Zhu

Tian Zhou

Qing-Jun Gao

Dai-Wei Zhao

Affiliations

Soon will be listed here.

Abstract

Alpha-actin-1 (ACTN1) is a cytoskeletal protein, and new evidence suggests that it is associated with tumor progression and prognosis. However, the expression of ACTN1 in thyroid carcinoma (THCA) and its biological functions are not fully understood. This study aimed to explore the expression and biological function of ACTN1 in THCA. Bioinformatics analysis revealed that ACTN1 was significantly upregulated in THCA and was associated with tumor size, extraglandular invasion, lymph node and distant metastasis, patient prognosis, and immune cell infiltration. qRT-PCR, immunohistochemistry, and western blotting verified the high expression of ACTN1 in the PTC samples. In vitro and in vivo experiments showed that overexpression of ACTN1 promoted THCA cell proliferation, cell cycle, migration, and invasion, and induced epithelial-mesenchymal transition (EMT); knockdown of ACTN1 inhibited these malignant behaviors. Mechanistically, ACTN1 knockdown reduced the phosphorylation levels of PI3K, AKT, and mTOR, whereas its overexpression increased these levels. After treating ACTN1 knockdown cells with the PI3K activator 740Y-P, the invasion and migration ability of the tumor was restored, suggesting that ACTN1 may promote the invasion and migration of THCA by activating the PI3K/AKT/mTOR pathway. In conclusion, ACTN1 is an important regulator of THCA progression and may serve as a potential molecular marker for predicting THCA invasion and metastasis.

References

Tanaka N, Yamashita T, Yamamoto S, Matsunobu T, Tsuda H, Honda K . Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer. Anticancer Res. 2014; 34(6):3157-63. View

Gerstberger S, Jiang Q, Ganesh K . Metastasis. Cell. 2023; 186(8):1564-1579. PMC: 10511214. DOI: 10.1016/j.cell.2023.03.003. View

Fahey M, Bennett M, Mahon C, Jager S, Pache L, Kumar D . GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics. 2011; 12:298. PMC: 3213248. DOI: 10.1186/1471-2105-12-298. View

Jiang Y, Yang M, Wang S, Li X, Sun Y . Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun (Lond). 2020; 40(4):154-166. PMC: 7170661. DOI: 10.1002/cac2.12012. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Yan Y, Zhang D, Zhou P, Li B, Huang S . HDOCK: a web server for protein-protein and protein-DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res. 2017; 45(W1):W365-W373. PMC: 5793843. DOI: 10.1093/nar/gkx407. View

Boucai L, Zafereo M, Cabanillas M . Thyroid Cancer: A Review. JAMA. 2024; 331(5):425-435. DOI: 10.1001/jama.2023.26348. View

Shao H, Wang J, Pollak M, Wells A . α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One. 2010; 5(11):e13921. PMC: 2978680. DOI: 10.1371/journal.pone.0013921. View

Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T . MEXPRESS update 2019. Nucleic Acids Res. 2019; 47(W1):W561-W565. PMC: 6602516. DOI: 10.1093/nar/gkz445. View

10.

Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

11.

Foley K, Young P . The non-muscle functions of actinins: an update. Biochem J. 2014; 459(1):1-13. DOI: 10.1042/BJ20131511. View

12.

Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P . Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2024; 1(3):e36. PMC: 10989974. DOI: 10.1002/imt2.36. View

13.

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

14.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

15.

. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2022; 51(D1):D523-D531. PMC: 9825514. DOI: 10.1093/nar/gkac1052. View

16.

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

17.

Murphy A, Young P . The actinin family of actin cross-linking proteins - a genetic perspective. Cell Biosci. 2015; 5:49. PMC: 4550062. DOI: 10.1186/s13578-015-0029-7. View

18.

Blanchard A, Ohanian V, Critchley D . The structure and function of alpha-actinin. J Muscle Res Cell Motil. 1989; 10(4):280-9. DOI: 10.1007/BF01758424. View

19.

Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader G . GeneMANIA update 2018. Nucleic Acids Res. 2018; 46(W1):W60-W64. PMC: 6030815. DOI: 10.1093/nar/gky311. View

20.

Bartha A, Gyorffy B . TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021; 22(5). PMC: 7961455. DOI: 10.3390/ijms22052622. View